Expression of CD44 is upregulated in premalignant lesions and is associated with particular cancer types, including prostate cancer, head and neck squamous-cell carcinoma, central nervous system malignancies, respiratory track malignancies, melanoma and breast cancer [27–30]. The gene discussed is CD44; the disease is cancer.